IDH2 and glioma: Figure 1b demonstrates that the 2-HG peak at 2.24 ppm is hardly distinguishable from the Glu/Gln peaks. Consequently, predicting IDH mutation in glioma solely based on the 2-HG signal without the use of sophisticated pulse sequences specific for 2-HG detection might be unreliable.